PETER A. SEARS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Celldex Therapeutics, Inc.

Filing Date Source Excerpt
2006-04-19 Mr. Sears has been a director since May 1999. Since August 2004, Mr. Sears has served as a consultant to Quaker BioVenures, a venture capital fund. He retired in 1999 as Vice President, Business Investments, SmithKline Beecham Corporation (now GlaxoSmithKline), and President and Founder of S.R. One, Limited, SmithKline's venture capital fund.
2007-04-20 Mr. Sears has served as a consultant to Quaker BioVentures, a venture capital fund. He retired in 1999 as Vice President, Business Investments, SmithKline Beecham Corporation (now GlaxoSmithKline), and President and Founder of S.R. One, Limited, SmithKline's venture capital fund.

Data sourced from SEC filings. Last updated: 2025-07-01